Recent Finacing
Recent Raise
RedDress develops autologous, blood-derived wound management systems (ActiGraft) for chronic and acute wounds, with FDA clearance, CE Mark, and commercial availability across 40 countries.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
